nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.117	0.463	CbGbCtD
Tadalafil—CYP3A4—Progesterone—uterine cancer	0.0774	0.306	CbGbCtD
Tadalafil—CYP3A4—Etoposide—uterine cancer	0.0346	0.137	CbGbCtD
Tadalafil—CYP3A4—Doxorubicin—uterine cancer	0.0236	0.0935	CbGbCtD
Tadalafil—PDE5A—artery—uterine cancer	0.0219	0.216	CbGeAlD
Tadalafil—PDE11A—epithelium—uterine cancer	0.0218	0.216	CbGeAlD
Tadalafil—PDE5A—epithelium—uterine cancer	0.00829	0.082	CbGeAlD
Tadalafil—PDE5A—uterine cervix—uterine cancer	0.00822	0.0813	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—uterine cancer	0.00798	0.079	CbGeAlD
Tadalafil—PDE5A—renal system—uterine cancer	0.00769	0.0761	CbGeAlD
Tadalafil—PDE5A—female reproductive system—uterine cancer	0.00616	0.0609	CbGeAlD
Tadalafil—PDE5A—female gonad—uterine cancer	0.0056	0.0554	CbGeAlD
Tadalafil—PDE5A—vagina—uterine cancer	0.00557	0.0551	CbGeAlD
Tadalafil—PDE5A—lymph node—uterine cancer	0.0036	0.0356	CbGeAlD
Tadalafil—CYP3A4—renal system—uterine cancer	0.0024	0.0237	CbGeAlD
Tadalafil—CYP3A4—female reproductive system—uterine cancer	0.00192	0.019	CbGeAlD
Tadalafil—Immune system disorder—Etoposide—uterine cancer	0.000921	0.00142	CcSEcCtD
Tadalafil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00092	0.00142	CcSEcCtD
Tadalafil—Mediastinal disorder—Etoposide—uterine cancer	0.000918	0.00142	CcSEcCtD
Tadalafil—Eye pain—Epirubicin—uterine cancer	0.000915	0.00141	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000911	0.00141	CcSEcCtD
Tadalafil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.0014	CcSEcCtD
Tadalafil—Vomiting—Progesterone—uterine cancer	0.0009	0.00139	CcSEcCtD
Tadalafil—Rash—Progesterone—uterine cancer	0.000892	0.00138	CcSEcCtD
Tadalafil—Dermatitis—Progesterone—uterine cancer	0.000892	0.00138	CcSEcCtD
Tadalafil—Headache—Progesterone—uterine cancer	0.000887	0.00137	CcSEcCtD
Tadalafil—Hot flush—Epirubicin—uterine cancer	0.000883	0.00137	CcSEcCtD
Tadalafil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000878	0.00136	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000875	0.00135	CcSEcCtD
Tadalafil—Menopausal symptoms—Epirubicin—uterine cancer	0.000875	0.00135	CcSEcCtD
Tadalafil—Renal impairment—Epirubicin—uterine cancer	0.000868	0.00134	CcSEcCtD
Tadalafil—Fatigue—Dactinomycin—uterine cancer	0.000863	0.00133	CcSEcCtD
Tadalafil—Back pain—Etoposide—uterine cancer	0.000858	0.00133	CcSEcCtD
Tadalafil—Pain—Dactinomycin—uterine cancer	0.000855	0.00132	CcSEcCtD
Tadalafil—Muscle spasms—Etoposide—uterine cancer	0.000853	0.00132	CcSEcCtD
Tadalafil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00131	CcSEcCtD
Tadalafil—Eye pain—Doxorubicin—uterine cancer	0.000846	0.00131	CcSEcCtD
Tadalafil—Cerebrovascular accident—Epirubicin—uterine cancer	0.000843	0.0013	CcSEcCtD
Tadalafil—Nausea—Progesterone—uterine cancer	0.000841	0.0013	CcSEcCtD
Tadalafil—Pain in extremity—Epirubicin—uterine cancer	0.000826	0.00128	CcSEcCtD
Tadalafil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000818	0.00127	CcSEcCtD
Tadalafil—Hot flush—Doxorubicin—uterine cancer	0.000817	0.00126	CcSEcCtD
Tadalafil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000815	0.00126	CcSEcCtD
Tadalafil—Migraine—Epirubicin—uterine cancer	0.000813	0.00126	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00081	0.00125	CcSEcCtD
Tadalafil—Menopausal symptoms—Doxorubicin—uterine cancer	0.00081	0.00125	CcSEcCtD
Tadalafil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.00125	CcSEcCtD
Tadalafil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00125	CcSEcCtD
Tadalafil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000803	0.00124	CcSEcCtD
Tadalafil—Renal impairment—Doxorubicin—uterine cancer	0.000803	0.00124	CcSEcCtD
Tadalafil—Face oedema—Epirubicin—uterine cancer	0.000797	0.00123	CcSEcCtD
Tadalafil—Vertigo—Etoposide—uterine cancer	0.000797	0.00123	CcSEcCtD
Tadalafil—Abdominal pain—Dactinomycin—uterine cancer	0.000791	0.00122	CcSEcCtD
Tadalafil—Loss of consciousness—Etoposide—uterine cancer	0.00078	0.00121	CcSEcCtD
Tadalafil—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00078	0.00121	CcSEcCtD
Tadalafil—Cough—Etoposide—uterine cancer	0.000774	0.0012	CcSEcCtD
Tadalafil—Convulsion—Etoposide—uterine cancer	0.000769	0.00119	CcSEcCtD
Tadalafil—Hypertension—Etoposide—uterine cancer	0.000766	0.00118	CcSEcCtD
Tadalafil—Pain in extremity—Doxorubicin—uterine cancer	0.000764	0.00118	CcSEcCtD
Tadalafil—Liver function test abnormal—Epirubicin—uterine cancer	0.000762	0.00118	CcSEcCtD
Tadalafil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000762	0.00118	CcSEcCtD
Tadalafil—Chest pain—Etoposide—uterine cancer	0.000755	0.00117	CcSEcCtD
Tadalafil—Orthostatic hypotension—Epirubicin—uterine cancer	0.000754	0.00117	CcSEcCtD
Tadalafil—Abdominal pain upper—Epirubicin—uterine cancer	0.000754	0.00117	CcSEcCtD
Tadalafil—Migraine—Doxorubicin—uterine cancer	0.000752	0.00116	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00075	0.00116	CcSEcCtD
Tadalafil—Discomfort—Etoposide—uterine cancer	0.000746	0.00115	CcSEcCtD
Tadalafil—Breast disorder—Epirubicin—uterine cancer	0.000746	0.00115	CcSEcCtD
Tadalafil—Nasopharyngitis—Epirubicin—uterine cancer	0.000738	0.00114	CcSEcCtD
Tadalafil—Face oedema—Doxorubicin—uterine cancer	0.000738	0.00114	CcSEcCtD
Tadalafil—Hypersensitivity—Dactinomycin—uterine cancer	0.000737	0.00114	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—uterine cancer	0.000731	0.00113	CcSEcCtD
Tadalafil—Infection—Etoposide—uterine cancer	0.000719	0.00111	CcSEcCtD
Tadalafil—Asthenia—Dactinomycin—uterine cancer	0.000718	0.00111	CcSEcCtD
Tadalafil—Influenza—Epirubicin—uterine cancer	0.000714	0.0011	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—uterine cancer	0.000714	0.0011	CcSEcCtD
Tadalafil—Tachycardia—Etoposide—uterine cancer	0.000707	0.00109	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—uterine cancer	0.000705	0.00109	CcSEcCtD
Tadalafil—Skin disorder—Etoposide—uterine cancer	0.000703	0.00109	CcSEcCtD
Tadalafil—Hyperhidrosis—Etoposide—uterine cancer	0.0007	0.00108	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000698	0.00108	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—uterine cancer	0.000698	0.00108	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—uterine cancer	0.000695	0.00108	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—uterine cancer	0.00069	0.00107	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—uterine cancer	0.000686	0.00106	CcSEcCtD
Tadalafil—Diarrhoea—Dactinomycin—uterine cancer	0.000684	0.00106	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—uterine cancer	0.000683	0.00106	CcSEcCtD
Tadalafil—Hypotension—Etoposide—uterine cancer	0.000677	0.00105	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—uterine cancer	0.000676	0.00105	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000663	0.00103	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—uterine cancer	0.00066	0.00102	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—uterine cancer	0.00066	0.00102	CcSEcCtD
Tadalafil—Paraesthesia—Etoposide—uterine cancer	0.00065	0.00101	CcSEcCtD
Tadalafil—Dyspnoea—Etoposide—uterine cancer	0.000646	0.000998	CcSEcCtD
Tadalafil—Somnolence—Etoposide—uterine cancer	0.000644	0.000996	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—uterine cancer	0.000643	0.000995	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—uterine cancer	0.000636	0.000984	CcSEcCtD
Tadalafil—Infestation—Epirubicin—uterine cancer	0.000636	0.000984	CcSEcCtD
Tadalafil—Vomiting—Dactinomycin—uterine cancer	0.000636	0.000984	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—uterine cancer	0.000635	0.000982	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000631	0.000976	CcSEcCtD
Tadalafil—Rash—Dactinomycin—uterine cancer	0.000631	0.000976	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—uterine cancer	0.000626	0.000968	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000625	0.000967	CcSEcCtD
Tadalafil—Fatigue—Etoposide—uterine cancer	0.000624	0.000966	CcSEcCtD
Tadalafil—Pain—Etoposide—uterine cancer	0.000619	0.000958	CcSEcCtD
Tadalafil—Constipation—Etoposide—uterine cancer	0.000619	0.000958	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—uterine cancer	0.000619	0.000957	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—uterine cancer	0.000619	0.000957	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000614	0.000949	CcSEcCtD
Tadalafil—Sweating—Epirubicin—uterine cancer	0.00061	0.000944	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—uterine cancer	0.000607	0.000938	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—uterine cancer	0.0006	0.000928	CcSEcCtD
Tadalafil—Nausea—Dactinomycin—uterine cancer	0.000594	0.000919	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—uterine cancer	0.000592	0.000916	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—uterine cancer	0.000589	0.000911	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—uterine cancer	0.000589	0.000911	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000584	0.000903	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—uterine cancer	0.000579	0.000895	CcSEcCtD
Tadalafil—Urticaria—Etoposide—uterine cancer	0.000575	0.00089	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—uterine cancer	0.000574	0.000888	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—uterine cancer	0.000573	0.000886	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—uterine cancer	0.000572	0.000885	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—uterine cancer	0.000572	0.000885	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—uterine cancer	0.000572	0.000885	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—uterine cancer	0.000571	0.000884	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—uterine cancer	0.000568	0.000879	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—uterine cancer	0.000567	0.000877	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—uterine cancer	0.000564	0.000873	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—uterine cancer	0.000564	0.000873	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—uterine cancer	0.000563	0.00087	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—uterine cancer	0.000561	0.000868	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—uterine cancer	0.000561	0.000868	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—uterine cancer	0.00056	0.000866	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—uterine cancer	0.000555	0.000859	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—uterine cancer	0.00054	0.000835	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—uterine cancer	0.000534	0.000826	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—uterine cancer	0.000533	0.000825	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—uterine cancer	0.000533	0.000824	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—uterine cancer	0.000531	0.000822	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—uterine cancer	0.00053	0.00082	CcSEcCtD
Tadalafil—Flushing—Epirubicin—uterine cancer	0.00053	0.00082	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—uterine cancer	0.00053	0.00082	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—uterine cancer	0.000529	0.000818	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—uterine cancer	0.000526	0.000813	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—uterine cancer	0.000525	0.000811	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—uterine cancer	0.000522	0.000807	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—uterine cancer	0.000521	0.000805	CcSEcCtD
Tadalafil—Asthenia—Etoposide—uterine cancer	0.000519	0.000804	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—uterine cancer	0.000519	0.000803	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—uterine cancer	0.000518	0.000802	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—uterine cancer	0.000518	0.000801	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—uterine cancer	0.000516	0.000798	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—uterine cancer	0.000515	0.000796	CcSEcCtD
Tadalafil—Pruritus—Etoposide—uterine cancer	0.000512	0.000792	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—uterine cancer	0.0005	0.000774	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—uterine cancer	0.0005	0.000773	CcSEcCtD
Tadalafil—Diarrhoea—Etoposide—uterine cancer	0.000495	0.000766	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—uterine cancer	0.000494	0.000764	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—uterine cancer	0.000493	0.000762	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—uterine cancer	0.000491	0.000759	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—uterine cancer	0.000491	0.000759	CcSEcCtD
Tadalafil—Back pain—Epirubicin—uterine cancer	0.000481	0.000744	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—uterine cancer	0.00048	0.000742	CcSEcCtD
Tadalafil—Dizziness—Etoposide—uterine cancer	0.000479	0.000741	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—uterine cancer	0.000478	0.00074	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—uterine cancer	0.000477	0.000738	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—uterine cancer	0.000476	0.000737	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—uterine cancer	0.000469	0.000725	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—uterine cancer	0.000463	0.000716	CcSEcCtD
Tadalafil—Vomiting—Etoposide—uterine cancer	0.00046	0.000712	CcSEcCtD
Tadalafil—Rash—Etoposide—uterine cancer	0.000457	0.000706	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—uterine cancer	0.000456	0.000705	CcSEcCtD
Tadalafil—Headache—Etoposide—uterine cancer	0.000454	0.000702	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—uterine cancer	0.000447	0.000691	CcSEcCtD
Tadalafil—Syncope—Epirubicin—uterine cancer	0.000446	0.00069	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—uterine cancer	0.000445	0.000688	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—uterine cancer	0.000442	0.000684	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—uterine cancer	0.000439	0.00068	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—uterine cancer	0.000437	0.000676	CcSEcCtD
Tadalafil—Cough—Epirubicin—uterine cancer	0.000434	0.000671	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—uterine cancer	0.000434	0.000671	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—uterine cancer	0.000431	0.000666	CcSEcCtD
Tadalafil—Nausea—Etoposide—uterine cancer	0.00043	0.000665	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—uterine cancer	0.000429	0.000664	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—uterine cancer	0.000423	0.000655	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—uterine cancer	0.000423	0.000655	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—uterine cancer	0.000423	0.000655	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00042	0.00065	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—uterine cancer	0.000418	0.000647	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—uterine cancer	0.000414	0.00064	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—uterine cancer	0.000413	0.000639	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—uterine cancer	0.000413	0.000638	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—uterine cancer	0.000407	0.000629	CcSEcCtD
Tadalafil—Oedema—Epirubicin—uterine cancer	0.000406	0.000628	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—uterine cancer	0.000404	0.000626	CcSEcCtD
Tadalafil—Infection—Epirubicin—uterine cancer	0.000403	0.000624	CcSEcCtD
Tadalafil—Cough—Doxorubicin—uterine cancer	0.000402	0.000621	CcSEcCtD
Tadalafil—Shock—Epirubicin—uterine cancer	0.000399	0.000618	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—uterine cancer	0.000399	0.000617	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—uterine cancer	0.000398	0.000616	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—uterine cancer	0.000397	0.000614	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—uterine cancer	0.000396	0.000613	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—uterine cancer	0.000394	0.00061	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—uterine cancer	0.000392	0.000607	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—uterine cancer	0.000392	0.000606	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—uterine cancer	0.000392	0.000606	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—uterine cancer	0.000392	0.000606	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000389	0.000602	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—uterine cancer	0.000387	0.000599	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—uterine cancer	0.000383	0.000593	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—uterine cancer	0.000379	0.000587	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—uterine cancer	0.000376	0.000581	CcSEcCtD
Tadalafil—Infection—Doxorubicin—uterine cancer	0.000373	0.000577	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00037	0.000572	CcSEcCtD
Tadalafil—Shock—Doxorubicin—uterine cancer	0.000369	0.000571	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—uterine cancer	0.000368	0.00057	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—uterine cancer	0.000367	0.000568	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—uterine cancer	0.000367	0.000567	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—uterine cancer	0.000365	0.000564	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—uterine cancer	0.000364	0.000564	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—uterine cancer	0.000363	0.000562	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—uterine cancer	0.000362	0.00056	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—uterine cancer	0.000361	0.000558	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—uterine cancer	0.000357	0.000553	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—uterine cancer	0.000351	0.000543	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00035	0.000542	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—uterine cancer	0.00035	0.000541	CcSEcCtD
Tadalafil—Constipation—Epirubicin—uterine cancer	0.000347	0.000537	CcSEcCtD
Tadalafil—Pain—Epirubicin—uterine cancer	0.000347	0.000537	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000342	0.000529	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—uterine cancer	0.00034	0.000525	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—uterine cancer	0.000337	0.000522	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—uterine cancer	0.000335	0.000518	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—uterine cancer	0.000334	0.000516	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—uterine cancer	0.000332	0.000513	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—uterine cancer	0.000331	0.000511	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000324	0.000501	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—uterine cancer	0.000324	0.000501	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—uterine cancer	0.000322	0.000499	CcSEcCtD
Tadalafil—Pain—Doxorubicin—uterine cancer	0.000321	0.000497	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—uterine cancer	0.000321	0.000497	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—uterine cancer	0.000321	0.000496	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000307	0.000475	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—uterine cancer	0.000299	0.000463	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—uterine cancer	0.000298	0.000461	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—uterine cancer	0.000297	0.000459	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—uterine cancer	0.000291	0.00045	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—uterine cancer	0.000287	0.000444	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—uterine cancer	0.000278	0.00043	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—uterine cancer	0.000277	0.000428	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—uterine cancer	0.000269	0.000417	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—uterine cancer	0.000268	0.000415	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—uterine cancer	0.000266	0.000411	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—uterine cancer	0.000258	0.000399	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—uterine cancer	0.000257	0.000397	CcSEcCtD
Tadalafil—Rash—Epirubicin—uterine cancer	0.000256	0.000396	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—uterine cancer	0.000256	0.000395	CcSEcCtD
Tadalafil—Headache—Epirubicin—uterine cancer	0.000254	0.000393	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—uterine cancer	0.000248	0.000384	CcSEcCtD
Tadalafil—Nausea—Epirubicin—uterine cancer	0.000241	0.000373	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—uterine cancer	0.000239	0.000369	CcSEcCtD
Tadalafil—Rash—Doxorubicin—uterine cancer	0.000237	0.000366	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—uterine cancer	0.000237	0.000366	CcSEcCtD
Tadalafil—Headache—Doxorubicin—uterine cancer	0.000235	0.000364	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—uterine cancer	0.000223	0.000345	CcSEcCtD
